Clinical Trials
3 trialsNCT03820817 2026-05-26
Rifaximin in Patients With Monoclonal Gammopathy
Emory University
Phase 1 Completed
NCT01345175 2024-05-14
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00967096 2013-11-27
Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)
Emory University
Phase 1 Completed